Maravai Lifesciences Holdings annual return on equity
2020
2021
2022
2023
2024
2025
Maravai Lifesciences Holdings Return on Equity (ROE) Growth & History (MRVI)
Maravai Lifesciences Holdings's return on equity was −48.64% for fiscal 2025.
View full Maravai Lifesciences Holdings company overviewMaravai Lifesciences Holdings annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −48.64% | −9.60 pp |
| 2024 | 2024-12-31 | −39.04% | −14.29 pp |
| 2023 | 2023-12-31 | −24.75% | −75.91 pp |
| 2022 | 2022-12-31 | 51.17% | −38.95 pp |
| 2021 | 2021-12-31 | 90.12% | +13.79 pp |
| 2020 · Dec 31 | 2020-12-31 | 76.33% | — |
Maravai Lifesciences Holdings quarterly return on equity
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −5.97% | +8.01 pp |
| Q1 2026 | 2026-03-31 | −1.76% | +7.81 pp |
| Q4 2025 | 2025-12-31 | −15.59% | −7.86 pp |
| Q3 2025 | 2025-09-30 | −10.00% | +14.91 pp |
| Q2 2025 | 2025-06-30 | −13.98% | −11.66 pp |
| Q1 2025 | 2025-03-31 | −9.57% | −6.65 pp |
| Q4 2024 | 2024-12-31 | −7.73% | +14.91 pp |
| Q3 2024 | 2024-09-30 | −24.90% | −23.66 pp |
| Q2 2024 | 2024-06-30 | −2.32% | −1.06 pp |
| Q1 2024 | 2024-03-31 | −2.92% | −2.91 pp |
| Q4 2023 | 2023-12-31 | −22.64% | −29.82 pp |
| Q3 2023 | 2023-09-30 | −1.24% | −10.50 pp |
| Q2 2023 | 2023-06-30 | −1.26% | −18.23 pp |
| Q1 2023 | 2023-03-31 | −0.01% | −19.17 pp |
| Q4 2022 | 2022-12-31 | 7.18% | −10.89 pp |
| Q3 2022 | 2022-09-30 | 9.26% | −12.47 pp |
| Q2 2022 | 2022-06-30 | 16.98% | −15.08 pp |
| Q1 2022 | 2022-03-31 | 19.16% | −3.82 pp |
| Q4 2021 | 2021-12-31 | 18.06% | — |
| Q3 2021 | 2021-09-30 | 21.73% | — |
| Q2 2021 | 2021-06-30 | 32.06% | — |
| Q1 2021 | 2021-03-31 | 22.97% | — |
Maravai Lifesciences Holdings return on equity trends
Over the last five fiscal years, Maravai Lifesciences Holdings's return on equity decreased from 76.33% to −48.64%, a change of −124.97 percentage points. The latest reported quarter, Q2 2026, shows −5.97%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maravai Lifesciences Holdings source filings ↗